MEN1 and gastrin-producing neuroendocrine tumor: The timing and indication of surgery for MEN1-related gastrinomas remain controversial as an excellent prognosis has been observed in non-operated patients with 10-year survival rates of 54% in cases with disseminated distant metastases, while acid-related complications may be effectively treated with PPIs [7,71].